Folds Josh C sold $16K of FBLA

Folds Josh C (Chief Banking Officer) sold 1,110 shares of FB Bancorp, Inc. /MD/ (FBLA) at $14.55 on 2026-06-22.

Original reporting
SEC EDGAR · Folds Josh C
Published Jun 25, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 6:54 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$FBLA
Neutral
low confidence
Mentioned
$FBLA
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FBLANeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale of 1,110 shares at $14.55, with holdings after the sale of 30,746 shares.

02

Market read

This provides a fresh insider-selling datapoint, but without any accompanying fundamental or regulatory development.

03

What to watch

The filing notes no pre-arranged 10b5-1 plan, but the article does not indicate intent, liquidity needs, or whether other insiders sold/bought around the same time.

Relevance 3/10Novelty 3/10Timing: filed 2026-06-25, transaction dated 2026-06-22

Background

The article is an SEC Form 4 insider transaction disclosure for FB Bancorp, Inc. (FBLA), reported by CFO Josh C Folds.

Company-level read

Ticker impact

$FBLANeutralLow confidence
Context

SEC Form 4 shows CFO Josh C Folds sold 1,110 shares of FB Bancorp at $14.55 on 2026-06-22, totaling $16,150.50.

Expected impact

Likely limited near-term impact; treat as low-signal unless repeated or paired with other negative disclosures.

Evidence & confidence

The filing is a primary-source insider transaction, but the article provides no accompanying operational, financial, or regulatory catalyst, and the transaction size is modest.

Market effects

No sector-level implications are provided; this is a single-company insider transaction.

None stated.

None stated.

Counterpoint

Insider sales can be routine for diversification or tax/estate planning, especially when not tied to a broader negative narrative.

Key entities

  • FB Bancorp, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Josh C Folds

    Chief Banking Officer who sold shares via open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FBLALow

FB Bancorp, Inc. /MD/ (FBLA): Announces Third Quarter 2026 Financial Results

FB Bancorp, Inc. /MD/ (FBLA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FB Bancorp, Inc. Announces Third Quarter 2026 Financial Results New Orleans, Louisiana, November 6, 2026 / FB Bancorp, Inc. (NASDAQ: “FBLA”) (the “Company”), the holding company for Fidelity Bank (the “Bank”), today announced net income for the nine months ended Sept

$FBLAMed

FB Bancorp, Inc. /MD/ (FBLA): Announces Second Quarter 2026 Financial Results

FB Bancorp, Inc. /MD/ (FBLA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ck0002013639-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 FB Bancorp, Inc. Announces Second Quarter 2026 Financial Results New Orleans, Louisiana, July 28, 2026 / FB Bancorp, Inc. (NASDAQ: “FBLA”) (the “Company”), the holding company for Fidelity Bank (the “Bank”), today ann

$MDGLMedAI 8/10

BAKER BROS. ADVISORS LP (BAKER FELIX, BAKER JULIAN) purchased $35.0M of MDGL (indirect holdings)

BAKER BROS. ADVISORS LP purchased 91,806 indirectly-held shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) at an average of $381.49 ($366.99–$396.61, $35.02M total) across 5 trades over 2026-11-04 to 2026-11-06. Filed jointly with Baker Bros. Advisors (GP) LLC (Director), BAKER FELIX (Director), BAKER JULIAN (Director), 667, L.P. (Director) and Baker Brothers Life Sciences LP (Director).